Victory Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Victory Financial Group's PFE Position: Q2 2026 in Review
Victory Financial Group reduced its Pfizer (PFE) stake by 6.6% in Q2 2026, selling an estimated $27.7K and leaving 15,030 shares worth $362K. The position accounts for 0.04% of the portfolio, ranked #255.
Victory Financial Group first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $452K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Victory Financial Group held 15,030 shares of Pfizer worth $362K as of Q2 2026.
- Victory Financial Group sold 1,058 Pfizer shares in Q2 2026, an estimated $27.7K.
- Pfizer made up 0.04% of Victory Financial Group's portfolio in Q2 2026, its #255 holding.
- Victory Financial Group first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
- Victory Financial Group's Pfizer position peaked at $452K in Q1 2026.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Victory Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.